TPP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.161200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.509190E-01
Normal-vs-Stage2
3.775800E-03
Normal-vs-Stage3
2.894100E-02
Normal-vs-Stage4
2.285200E-01
Stage1-vs-Stage2
6.118800E-01
Stage1-vs-Stage3
1.915820E-01
Stage1-vs-Stage4
2.091400E-01
Stage2-vs-Stage3
1.535550E-01
Stage2-vs-Stage4
3.815600E-01
Stage3-vs-Stage4
1.143220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.198500E-03
Normal-vs-AfricanAmerican
1.242420E-01
Normal-vs-Asian
2.286200E-02
Caucasian-vs-AfricanAmerican
6.470000E-01
Caucasian-vs-Asian
3.666000E-01
AfricanAmerican-vs-Asian
4.484600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.262400E-03
Normal-vs-Female
5.619500E-03
Male-vs-Female
5.990600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.407160E-01
Normal-vs-Age(41-60Yrs)
1.880480E-02
Normal-vs-Age(61-80Yrs)
9.993300E-04
Normal-vs-Age(81-100Yrs)
3.082000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.144000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.086400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.604200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.44309999999759E-05
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.809700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.402200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.881290E-03
Normal-vs-Daily Drinker
2.318300E-03
Normal-vs-Weekly Drinker
4.674100E-02
Normal-vs-Occasional Drinker
4.855600E-02
Normal-vs-Social Drinker
8.859500E-02
Non Drinker-vs-Daily Drinker
8.887200E-01
Non Drinker-vs-Weekly Drinker
1.959780E-01
Non Drinker-vs-Occasional Drinker
4.997600E-02
Non Drinker-vs-Social Drinker
3.214500E-02
Daily Drinker-vs-Weekly Drinker
2.517000E-01
Daily Drinker-vs-Occasional Drinker
7.624200E-02
Daily Drinker-vs-Social Drinker
4.974500E-02
Weekly Drinker-vs-Occasional Drinker
6.691000E-01
Weekly Drinker-vs-Social Drinker
5.081200E-01
Occasional Drinker-vs-Social Drinker
7.681200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.846400E-01
Normal-vs-Grade 2
8.967400E-01
Normal-vs-Grade 3
8.947800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.299370E-01
Grade 1-vs-Grade 3
1.971790E-01
Grade 1-vs-Grade 4
9.846400E-01
Grade 2-vs-Grade 3
9.645000E-01
Grade 2-vs-Grade 4
8.967400E-01
Grade 3-vs-Grade 4
8.947800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.251900E-02
Normal-vs-NonDiabetic
1.242060E-03
Diabetic-vs-NonDiabetic
2.655200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.584800E-03
Normal-vs-NoPancreatitis
4.517200E-03
Pancreatitis-vs-NoPancreatitis
7.609400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.579900E-03
Normal-vs-N1
4.484400E-03
N0-vs-N1
7.368800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.016500E-03
Normal-vs-TP53-NonMutant
3.602400E-03
TP53-Mutant-vs-TP53-NonMutant
9.605200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
